Publication:
Vancomycin versus Placebo for Treating Persistent Fever in Patients with Neutropenic Cancer Receiving Piperacillin-Tazobactam Monotherapy

Simple item page
dc.contributor.authorKORTEN, VOLKAN
dc.contributor.authorsCometta, A.; Kern, W. V.; De Bock, R.; Paesmans, M.; Vandenbergh, M.; Crokaert, F.; Engelhard, D.; Marchetti, O.; Akan, H.; Skoutelis, A.; Korten, V.; Vandercam, M.; Gaya, H.; Padmos, A.; Klastersky, J.; Zinner, S.; Glauser, M. P.; Calandra, T.; Viscoli, C.; The International Antimicrobial Therapy Group of the European Organization for Research Treatment of Cancer
dc.date.accessioned2022-03-02T05:46:34Z
dc.date.accessioned2026-01-10T19:37:28Z
dc.date.available2022-03-02T05:46:34Z
dc.date.issued2003-08-01
dc.identifier.doi10.1086/376637
dc.identifier.issn1058-4838, 1537-6591
dc.identifier.issue3
dc.identifier.pages382-389
dc.identifier.urihttps://hdl.handle.net/11424/218893
dc.identifier.volume37
dc.language.isoeng
dc.relation.urihttps://academic.oup.com/cid/article-lookup/doi/10.1086/376637
dc.titleVancomycin versus Placebo for Treating Persistent Fever in Patients with Neutropenic Cancer Receiving Piperacillin-Tazobactam Monotherapy
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
179.42 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları